A research team led by Professor Jung Se-young of the Department of Family Medicine at Seoul National University Bundang ...

Korean pharmaceutical and biotechnology companies will present cancer drug development data at ESMO Congress 2026 in Madrid ...

Hanmi Pharmaceutical's first domestically developed GLP-1 obesity drug has won regulatory approval in Korea, setting up ...

Korean biotech PRG S&Tech has begun enrolling patients in a U.S. phase 2 clinical trial of Progerinin, an experimental ...

With its second oligonucleotide manufacturing plant now in full operation, ST Pharm is using CPHI Worldwide 2026 in Milan, ...

Nearly three-quarters of foreign patient visits to medical departments in Korea last year were for dermatology or plastic ...

CG MedTech has secured regulatory approval in Colombia for its INNOVERSE Spinal System and plans to introduce the spinal ...

HanAll Biopharma has expanded its hair loss treatment portfolio with the launch of Pangro Solution 5%, an over-the-counter ...

Korea has warned people against using generative AI chatbots to diagnose depression or other mental illnesses, after a government survey found that one in three respondents who rated their mental heal ...

GI Innovation said Wednesday that its Japanese partner Maruho plans to dose the first patient in a phase 2 trial of allergy ...

Despite major advances in psoriasis treatment, many Korean patients remain undertreated and face social stigma, prompting ...

A Seoul court has ordered a doctor to pay 10 million won ($7,467) in damages for performing a cosmetic procedure without a ...